P08 TEMPORAL TRENDS IN PROGNOSIS OF PATIENTS WITH SMOLDERING MULTIPLE MYELOMA (SMM) WHO MEET CRITERIA FOR BIOMARKER-DEFINED EARLY MULTIPLE MYELOMA (SLIM CRAB POSITIVE MM) by H. Ludwig, S. Kainz, N. Zojer, M. Schreder, A. Hinke

Get full text

P873: CARFILZOMIB RESISTANCE IS ASSOCIATED WITH SIGNIFICANT DEREGULATION OF THE BH3 FAMILY PROTEINS by A. Schneller, A. Bolomsky, N. Zojer, M. Schreder, H. Ludwig

Get full text

P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION by C. Pfeiffer, P. Beer, H. Asnagli, A. Bolomsky, A. Grandits, A. Schneller, J. Huber, N. Zojer, M. Schreder, A. Parker, H. Ludwig

Get full text

S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON-ELIGIBLE PATIENTS WITH NDMM (AGMT-MM02 TRIAL) by H. Ludwig, T. Melchardt, S. Sormann, N. Zojer, J. Andel, B. Hartmann, C. Tinchon, E. Gunsilius, K. Podar, A. Egle, W. Willenbacher, E. Wöll, M. Schreder, R. Ruckser, B Bozic, M.-T. Krauth, A. Petzer, C Schmitt, S. Machherndl-Spandl, H. Agis, M. Fillitz, W. Pönisch, S. Knop, B. Paiva, R. Greil

Get full text